Skip to main content
HR 6065 114th Congress House

Synthetic Drug Overdose Prevention and Education Act

Official title: To amend the Public Health Service Act with respect to the prevention and treatment of the use of synthetic recreational drugs, and for other purposes.

Introduced: September 15, 2016 Introduced by: Velázquez, Nydia M. Democratic · New York See on congress.gov
Health Congressional oversightDrug trafficking and controlled substancesDrug, alcohol, tobacco useGovernment information and archives
More subjectsShow fewer subjects
Government studies and investigationsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careLaw enforcement officers
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 15, 2016
Referred to the House Committee on Energy and Commerce.
Sep 15, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 15, 2016

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Synthetic Drug Overdose Prevention and Education Act

This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention (CDC) to study strategies for preventing and treating the use of synthetic recreational drugs, which are substances marketed for recreational use (regardless of claims to the contrary) that are analogous to a controlled substance and are not medications.

The Department of Health and Human Services must coordinate with the Drug Enforcement Administration (DEA) to establish and maintain a database of synthetic recreational drugs. The database must be publicly available for use in preventing and treating the use of synthetic recreational drugs.

The CDC, in collaboration with the Substance Abuse and Mental Health Services Administration, the National Institute on Drug Abuse, the National Institutes of Health, and the DEA, must develop and implement a national outreach campaign to educate law enforcement personnel, health care professionals, community members, and others about preventing and treating the use of substances similar to marijuana (cannabimimetic agents).

The CDC may award grants to federally qualified health centers for public awareness programs regarding substances similar to marijuana.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Clarke, Yvette D.
New York · Sep 15, 2016
 D
Jeffries, Hakeem S.
New York · Sep 15, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6065: Synthetic Drug Overdose Prevention and Education Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-6065/
MLA
"H.R. 6065: Synthetic Drug Overdose Prevention and Education Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-6065/.
Bluebook (legal)
H.R. 6065, 114th Cong. (2026), https://openamerica.io/bill/114-HR-6065/.
Markdown link
[H.R. 6065: Synthetic Drug Overdose Prevention and Education Act](https://openamerica.io/bill/114-HR-6065/)
Report a problem